Abstract: The marking of a video stream to impart a unique identifier commences by first identifying portions within the video stream readily susceptible to change in a visually imperceptible manner. Thereafter, a combination of visually imperceptible changes is applied to the identified portions at random intervals for randomly varying intervals to mark the video stream. Each change in the stream correlates a particular bit sequence so that a combination of different changes yields a string of bit sequences that can particularly identify the stream.

Abstract: The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.

Abstract: An electronic program guide includes a plurality of elements arrayed in a grid of rows and columns, with the rows corresponding to program sources and the columns corresponding to time intervals. Each element corresponds to a program played out from a particular program source during a corresponding time interval. The background of each element changes, such as by way of a color gradient or changing shape, to indicate one of a program beginning or ending. In this way, a viewer can ascertain the length of the program even if the element gets clipped upon updating the electronic program guide.

Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Abstract: A system and method for enabling a user to display and interact with a social networking structure on a video device connected to a network enabled host device is provided. A user interface (UI) 700 is also provided for displaying content (e.g. messages or tweets) that is output in an overlay for display on a display while program video is playing. The method provides for accessing a social networking site in response to a user input, the user input initiated while outputting a program for display, generating at least one keyword for searching the social networking site based on at least one characteristic associated with the program, retrieving content from the social networking site based the at least one keyword and outputting the retrieved content in an overlay for display simultaneous with the program.

Abstract: A system and method for enabling a user to interact with a social networking structure for an internet website on a video device connected to a network enabled host device is provided. The present disclosure provides for accessing an internet site in response to a user input, the user input initiated while outputting a program to a display, retrieving content from the internet site based on at least one characteristic associated with the program, and outputting the retrieved content in an overlay or user interface on the display simultaneous with the program. The user interface provides the ability to access multiple profiles for determining whose content or message to display, and also includes a rotating carousel message display system, with a current message surrounded above and below by a previous message and a next message in the display queue in a different size or font.

Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Abstract: There is provided pyrimidinyl compounds of Formula (I), wherein: R2 is or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.

Abstract: Certain exemplary embodiments comprise a method comprising a plurality of activities comprising via a graphical editor running on a Human Machine Interface comprising a first embedded operating system, providing a plurality of set points related to a process to a programmable logic controller. The method can comprise, via the programmable logic controller, automatically controlling the process responsive to information received from the graphical editor.

Abstract: There is provided pyrimidinyl indole compounds of Formula (I), or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Abstract: The invention provided a compound of formula: (I) for use in the treatment of disease, in particular proliferative diseases such as cancer and for use in the preparation of medicaments for use in the treatment of proliferative diseases; the invention also processes for the preparation of such compounds, as well as pharmaceutical compositions containing them as active ingredient.

Abstract: The invention concerns indole derivatives of Formula I or pharmaceutically-acceptable salts thereof, wherein each of Ring A, m, R1, R2, n, R3 and G1 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.

Abstract: The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R1, R2, R3, R4 and R5 are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.

Abstract: The invention concerns pyrazole derivatives of Formula I or pharmaceutically-acceptable salts thereof, wherein each of R, Ring A, m, R1, R2 and R3 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of disease mediated by a PI3K enzyme and/or a mTOR kinase.